SHATTUCK LABS, INC.
Ownership & governance
Executives 5Directors 7Avg age 58Avg tenure 4.4y
TS
Taylor Schreiber
Chief Executive Officer
Age 46Since 2019-12-31Profile →
+11
Executives5
Board of directors7
GG
George Golumbeski→
Chairman
Age 68Since 2021-10-21
TS
Taylor Schreiber→
Director/Board Member
Age 46Since 2019-12-31
NG
Neil Gibson→
Director/Board Member
Age 70Since 2016-10-31
HB
Helen Boudreau→
Director/Board Member
Age 60Since 2020-07-21
CS
Clay Siegall→
Director/Board Member
Age 65Since 2024-02-29
DB
Daniel Baker→
Director/Board Member
Age 75Since 2025-08-24
MA
Mona Ashiya→
Director/Board Member
Age 57Since 2025-08-24
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| T. Rowe Price Investment Management, Inc. | 12.87 % | 9,865,558 |
| Redmile Group LLC | 8.988 % | 6,892,033 |
| OrbiMed Advisors Private Equity | 8.224 % | 6,306,127 |
| Redmile Group LLC | 7.224 % | 5,539,724 |
| Prosight Management LP | 6.526 % | 5,004,439 |
Catalog · 2026-07-09
Registry officers12
| Name | Role | Since | Shares |
|---|---|---|---|
| Amy Franke | Chief Tech/Sci/R&D Officer | 2022-09-30 | - |
| Andrew Neill | Director of Finance/CFO | 2021-03-15 | - |
| George Golumbeski | Chairman | 2021-10-21 | - |
| Michael Choi | Chief Tech/Sci/R&D Officer | 2024-12-31 | - |
| Taylor Schreiber | Chief Executive Officer | 2019-12-31 | - |
| Clay Siegall | Director/Board Member | 2024-02-29 | - |
| Daniel Baker | Director/Board Member | 2025-08-24 | - |
| Helen Boudreau | Director/Board Member | 2020-07-21 | - |
Registry · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus strong buyMean target 15.4Range 10–19Analysts 10
10Mean 15.419
- Strong buy 3
- Buy 9
Broker actions40 of 66
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| UBS | Initiated | Buy | 17 | 2026-10-12 |
| Wedbush | Maintained | Outperform | 14 | 2026-10-02 |
| Needham | Maintained | Buy | 19 | 2026-10-02 |
| Raymond James | Initiated | Strong Buy | 18 | 2026-08-24 |
| HC Wainwright & Co. | Maintained | Buy | 14 | 2026-08-11 |
| JP Morgan | Initiated | Overweight | 10 | 2026-07-24 |
| Leerink Partners | Initiated | Outperform | 16 | 2026-07-20 |
| Citigroup | Maintained | Buy | 18 | 2026-06-09 |
| Needham | Maintained | Buy | 17 | 2026-06-08 |
| HC Wainwright & Co. | Reiterated | Buy | 18 | 2026-06-08 |
| Citigroup | Upgrade | Buy | 7 | 2026-06-05 |
| Wedbush | Maintained | Outperform | 11 | 2026-05-08 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.